Notice to Hospitals Regarding Ceftriaxone-Calcium Incompatibility: What's a Clinician to Do?
作者信息
Gin Alfred, Walker Sandra
机构信息
Pharmaceutical Services, Health Sciences Centre, Winnipeg, Manitoba.
出版信息
Can J Hosp Pharm. 2009 Mar;62(2):157-8. doi: 10.4212/cjhp.v62i2.447.
Abstract
摘要
相似文献
1
Notice to Hospitals Regarding Ceftriaxone-Calcium Incompatibility: What's a Clinician to Do?致医院关于头孢曲松与钙不相容性的通知：临床医生该怎么做？
Can J Hosp Pharm. 2009 Mar;62(2):157-8. doi: 10.4212/cjhp.v62i2.447.
2
Ceftriaxone-associated gallbladder sludge: what's in a name?头孢曲松相关的胆囊泥沙样沉积物：名称中有何含义？
Gastroenterology. 1991 Jun;100(6):1769-72. doi: 10.1016/0016-5085(91)90683-c.
3
Prediction of incompatibility of ceftriaxone sodium with calcium ions using the ionic product.利用离子积预测头孢曲松钠与钙离子的配伍禁忌
Yakugaku Zasshi. 2010 Jan;130(1):95-102. doi: 10.1248/yakushi.130.95.
4
The Role of an Impurity in Ceftriaxone Sodium Preparation for Injection in Determining Compatibility with Calcium-Containing Solutions.杂质在注射用头孢曲松钠制剂中对与含钙溶液相容性的影响
Chem Pharm Bull (Tokyo). 2016;64(3):207-14. doi: 10.1248/cpb.c15-00538.
5
Incompatibility of ceftriaxone sodium with calcium-containing products.头孢曲松钠与含钙产品的配伍禁忌。
Yakugaku Zasshi. 2009 Nov;129(11):1385-92. doi: 10.1248/yakushi.129.1385.
6
A commentary on the evolution of NIH: what's in, what's out, what's hot, what's not.关于美国国立卫生研究院发展历程的述评：哪些入选，哪些落选，哪些热门，哪些冷门。
Integr Physiol Behav Sci. 1998 Apr-Jun;33(2):115-7. doi: 10.1007/BF02688652.
7
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1994 Apr;7(2):203-4. doi: 10.1111/j.1540-8183.1994.tb00905.x.
8
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1992 Mar;5(1):67-8. doi: 10.1111/j.1540-8183.1992.tb00827.x.
9
Small animal dermatopathology: 'what's old, what's new, what's borrowed, what's useful'.小动物皮肤病理学：“旧闻、新闻、借鉴、实用”。
Semin Vet Med Surg Small Anim. 1987 Aug;2(3):162-5.
10
The Editor's Workshop: Pediatric and adolescent gynecology: What's the issue? What's the answer? What's the big picture? What's the national perspective?编辑工作室：儿科与青少年妇科：问题是什么？答案是什么？全局情况如何？全国视角怎样？
J Pediatr Adolesc Gynecol. 2009 Aug;22(4):195-6. doi: 10.1016/j.jpag.2009.06.001.
引用本文的文献
1
Cefotaxime Versus Ceftriaxone: A Comprehensive Comparative Review.头孢噻肟与头孢曲松：全面比较综述
Cureus. 2024 Sep 11;16(9):e69146. doi: 10.7759/cureus.69146. eCollection 2024 Sep.
2
Co-administration of Intravenous Drugs: Rapidly Troubleshooting the Solid Form Composition of a Precipitate in a Multi-drug Mixture Using On-Site Raman Spectroscopy.静脉药物共同给药：使用现场拉曼光谱快速解决多药物混合物中沉淀物的固体形式组成问题。
Mol Pharm. 2023 Jun 5;20(6):2853-2863. doi: 10.1021/acs.molpharmaceut.2c00983. Epub 2023 May 11.
3
Implementation of pharmacists' monitoring for intravenous drug compatibility.实施药师对静脉药物配伍的监测。
Eur J Hosp Pharm. 2023 Mar;30(2):101-106. doi: 10.1136/ejhpharm-2021-003187. Epub 2022 Sep 1.
本文引用的文献
1
Safety of ceftriaxone sodium at extremes of age.头孢曲松钠在极端年龄时的安全性。
Expert Opin Drug Saf. 2008 Sep;7(5):515-23. doi: 10.1517/14740338.7.5.515.
2
Clinical pharmaceutics and calcium-ceftriaxone.临床药剂学与头孢曲松钙
Ann Pharmacother. 2008 Mar;42(3):450-1. doi: 10.1345/aph.1K410a. Epub 2008 Jan 29.
3
Clinical pharmaceutics and calcium ceftriaxone.临床药剂学与头孢曲松钙
Ann Pharmacother. 2007 Dec;41(12):2072. doi: 10.1345/aph.1K410. Epub 2007 Nov 6.
4
Incompatibility of ceftriaxone sodium with lactated Ringer's injection.
Am J Health Syst Pharm. 1999 Feb 15;56(4):384. doi: 10.1093/ajhp/56.4.384.
Zotero 插件